Geron reported $119.83M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Amgen USD 51.89B 1.88B Mar/2026
Bio Techne USD 200M 60M Mar/2026
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 247.21M 868.77M Mar/2026
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
Geron USD 119.83M 286K Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Incyte USD 29.41M 785K Mar/2026
MacroGenics USD 70M 256K Dec/2025
Novartis USD 37.45B 7.86B Mar/2026
Novavax USD 246.3M 200K Dec/2025